Isoindolinone compounds | Patent Publication Number 20230348418

US 20230348418 A1

Patent NumberUS 11912682 B2

Application Number18349634

Filled DateJul 10, 2023

Priority DateNov 18, 2021

Publication DateNov 2, 2023

Original AssigneeMonte Rosa Therapeutics Inc.

Current AssigneeMonte Rosa Therapeutics Inc.

Inventor/ApplicantsThomas Ryckmans
Bernhard Fasching
Alexander Flohr

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.